Atlas Trials

A Study of Enzalutamide in Combination With AZD5363 in Patients With mCRPC

Clinical trial NCT02525068 · UNKNOWN

Trial details

NCT number
NCT02525068
Sponsor
Institute of Cancer Research, United Kingdom
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Adenocarcinoma of the Prostate
Start date
2014-12-01
Primary completion
2019-12-31
Enrollment
136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.